









Markets
/
Stocks
/
nasdaq-bbnx
/

Beta Bionics Inc

BBNX

31.860USD

+0.770+2.48%

Close 12/26, 16:00（ET）Quotes delayed by 15 min

1.40BMarket Cap

LossP/E TTM



Beta Bionics Inc

31.860

+0.770+2.48%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Beta Bionics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2023Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---8.73M

---13.59M

---19.98M

-124.97%-14.28M

---6.35M

Net income from continuing operations

---14.21M

---16.87M

---28.66M

3.93%-18.11M

---18.85M

Operating gains losses

--385.00K

--347.00K

--604.00K

-2.76%529.00K

--544.00K

Other non-cash items

--300.00K

---372.00K

---705.00K

-41.98%-1.04M

---736.00K

Change in working capital

--317.00K

---1.50M

---6.47M

-472.97%-3.24M

---566.00K

-Change in receivables

---168.00K

---2.33M

--2.94M

-84.01%-4.56M

---2.48M

-Change in inventory

---3.33M

---1.73M

---2.62M

-72.16%-1.58M

---916.00K

-Change in prepaid expenses

---1.79M

---1.99M

---1.62M

-308.70%-1.13M

---276.00K

-Change in other current assets

---39.00K

--2.00K

--4.00K

103.45%1.00K

---29.00K

-Change in other current liabilities

--711.00K

--1.54M

--480.00K

228.99%783.00K

--238.00K

Cash from non-recurring investing activities

Cash from operating activities

---8.73M

---13.59M

---19.98M

-124.97%-14.28M

---6.35M

Investing cash flow

Net cash from continuing investing activities

--1.28M

--1.78M

--333.00K

79.23%561.00K

--313.00K

Capital expenditures

--1.28M

--1.78M

--333.00K

79.23%561.00K

--313.00K

Net cash flow from disposal of fixed assets

--1.28M

--1.78M

--333.00K

79.23%561.00K

--313.00K

Net cash flow from investment products

--10.77M

--7.95M

---178.79M

58.00%-29.10M

---69.30M

Net cash flow from other investing activities

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

--9.49M

--6.17M

---179.12M

57.39%-29.66M

---69.61M

Financing cash flow

Cash flow from continuous financing activities

--2.65M

--42.00K

--211.12M

632033.33%56.89M

--9.00K

Net cash flow from common stock issuance/repurchase

--0.00

--211.02M

----

Net cash flow from preferred stock issuance/repurchase

----

--59.66M

--0.00

Proceeds from stock option exercised by employees

--2.65M

--42.00K

--98.00K

311.11%37.00K

--9.00K

Proceeds from issuance of warrants

----

--1.00K

--0.00

Net cash flow from other financing activities

----

---2.81M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

--2.65M

--42.00K

--211.12M

632033.33%56.89M

--9.00K

Net cash flow

Beginning cash balance

--35.17M

--42.55M

--30.53M

-82.87%17.58M

--102.61M

Current period cash flow changes

--3.41M

---7.38M

--12.02M

117.05%12.95M

---75.95M

Ending cash balance

--38.59M

--35.17M

--42.55M

14.50%30.53M

--26.67M

Free cash flow

---10.01M

---15.37M

---20.31M

-122.82%-14.84M

---6.66M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

